LYRA Insider Trading Activity and SEC Form 4 Filings
LYRA insider trading summary
Over the past 12 months, insiders at Lyra Therapeutics, Inc. (LYRA) reported 42 sales worth $1.4M by 6 insiders and no open-market purchases on SEC Form 4. Net insider selling was $1.4M.
Latest LYRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 6, 2026 | Maria Palasis | President & CEO | Sell | $6K (1,702 @ $3.36) |
| Jan 6, 2026 | Jason Cavalier | Chief Financial Officer | Sell | $3K (769 @ $3.36) |
| Nov 13, 2025 | Joseph Edelman | Insider | Sell | $112K (28,597 @ $3.90) |
| Nov 13, 2025 | Perceptive LS (A), LLC | Insider | Sell | $112K (28,597 @ $3.90) |
| Nov 13, 2025 | Perceptive Advisors LLC | Insider | Sell | $112K (28,597 @ $3.90) |
| Nov 13, 2025 | Joseph Edelman | Insider | Sell | $13K (3,213 @ $3.90) |
| Nov 13, 2025 | Perceptive Advisors LLC | Insider | Sell | $13K (3,213 @ $3.90) |
| Nov 13, 2025 | Perceptive Life Sciences Master Fund Ltd | Insider | Sell | $112K (28,597 @ $3.90) |
| Nov 13, 2025 | Perceptive Life Sciences Master Fund Ltd | Insider | Sell | $13K (3,213 @ $3.90) |
| Nov 13, 2025 | Perceptive LS (A), LLC | Insider | Sell | $13K (3,213 @ $3.90) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.